Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Med.

Sec. Pulmonary Medicine

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1594145

Meta-Analysis of High-Flow Nasal Cannula Oxygen Therapy Versus Non-Invasive Ventilation After Invasive Mechanical Ventilation

Provisionally accepted
Mailidan  MaimaitiniyaziMailidan Maimaitiniyazi1,2chenfei  Zhangchenfei Zhang1,2Muyesaier  MaimaitiniyaziMuyesaier Maimaitiniyazi2Meiheliya  MaisutiMeiheliya Maisuti2Ailifeire  AihaitiAilifeire Aihaiti1,2Tuersunayi  YisimitiTuersunayi Yisimiti1,2Yilizhati  NijiatiYilizhati Nijiati1,2Nijiati  MuyesaiNijiati Muyesai1,2*
  • 1People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi, China
  • 2Xinjiang Medical University, Ürümqi, Xinjiang Uyghur Region, China

The final, formatted version of the article will be published soon.

[Abstract] Objective: To compare high-flow nasal cannula (HFNC) oxygen therapy and non-invasive ventilation (NIV) for patients after liberation from invasive mechanical ventilation, to assess whether HFNC is better than NIV at improving blood gases [PaO₂, PaCO₂, and oxygenation index (OI)], reducing re-intubation rates, pulmonary infections, mortality, and shortening the length of stay in intensive care unit (ICU), and to evaluate if HFNC is a feasible alternative to NIV for respiratory support. Methods: This meta-analysis included randomized controlled trials (RCTs) and non-RCTs (NRCTs) from PubMed, Web of Science, CNKI, and Wanfang for further assessment. Evaluation indexes included PaO₂, PaCO₂, OI, re-intubation rate, pulmonary infection rate, length of stay in ICU, and mortality rate. Results: HFNC showed higher PaO₂ [MD=2.95, 95%CI (2.23,3.67), P<0.00001], lower PaCO₂ [MD=-3.04, 95%CI (-3.56,-2.52), P<0.00001], higher OI [MD=10.98, 95%CI (6.52,15.45), P<0.00001], lower re-intubation rate [OR=0.45, 95%CI (0.33,0.63), P<0.00001], and shorter length of stay in ICU [MD=-6.15, 95%CI (-6.86,-5.44), P<0.00001] compared to NIV. Additionally, no significant differences in pulmonary infection rate [OR=0.57, 95%CI (0.29,1.11), P=0.10] or mortality [OR=1.29, 95%CI (0.96,1.72), P=0.09] were observed between HFNC and NIV. Conclusion: HFNC can improve PaO₂ and OI, reduce PaCO₂, re-intubation rate, and length of stay in ICU, with no difference in pulmonary infection or mortality compared to NIV, supporting it as a viable clinical alternative for post-extubation respiratory support.

Keywords: HFNC, NIV, Invasive mechanical ventilation, Meta-analysis, respiratory failure

Received: 15 Mar 2025; Accepted: 26 Aug 2025.

Copyright: © 2025 Maimaitiniyazi, Zhang, Maimaitiniyazi, Maisuti, Aihaiti, Yisimiti, Nijiati and Muyesai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Nijiati Muyesai, People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.